Medical Device News Magazine

JN White Introduces the SnaggleClaw™

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

J.N. White Associates, Inc. (announced today that it is launching the SnaggleClaw™: a new multipurpose, touchless tool that limits exposure to pathogens.

The JN White ®  SnaggleClaw™is to be used in situations where an individual risks exposure to COVID-19.

This tool provides a safer alternative to touching in everyday activities, such as operating touchscreens, keypads and door handles. In addition, the tool contains an antimicrobial coating that offers an additional layer of defense against pathogens.

JN White® is an ISO 9001:2015 and ITAR-certified custom manufacturer specializing in the design and production of membrane switches, graphic overlays and custom labels. The company works with a wide range of global companies in many industries including military/DoD, medical devices and appliances. In response to the coronavirus pandemic, JN White® moved into the development and production of Personal Protective Equipment (PPE).

When asked why the firm continues to expand into new PPE products, JN White® President, Jason Aymerich, explains, “JN White® continues to innovate where the market has a need.  Providing solutions in the PPE space furthers the firm’s commitment to helping our country stay strong.”

SplatterGuard and SnaggleClaw are trademarks of J.N. White Associates, Inc. JN White and Precision Answers are registered trademarks of J.N. White Associates, Inc. 

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”